1. Home
  2. GRABW vs TECH Comparison

GRABW vs TECH Comparison

Compare GRABW & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grab Holdings Limited Warrant

GRABW

Grab Holdings Limited Warrant

N/A

Current Price

$0.29

Market Cap

0.0

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.87

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRABW
TECH
Founded
2012
1976
Country
Singapore
United States
Employees
11267
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
9.2B
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
GRABW
TECH
Price
$0.29
$58.87
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
$71.23
AVG Volume (30 Days)
54.7K
1.6M
Earning Date
02-21-2025
02-04-2026
Dividend Yield
N/A
0.54%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$2,686,000,000.00
$1,216,732,000.00
Revenue This Year
N/A
$2.33
Revenue Next Year
N/A
$7.05
P/E Ratio
N/A
$121.46
Revenue Growth
21.65
3.85
52 Week Low
$0.15
$46.01
52 Week High
$0.59
$79.28

Technical Indicators

Market Signals
Indicator
GRABW
TECH
Relative Strength Index (RSI) 37.58 45.70
Support Level $0.29 $58.54
Resistance Level $0.32 $59.64
Average True Range (ATR) 0.04 1.45
MACD -0.00 0.04
Stochastic Oscillator 32.53 49.84

Price Performance

Historical Comparison
GRABW
TECH

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: